Should Watson Be Consulted for a Second Opinion?
1An affiliate associate professor in the Department of Psychiatry and Behavioral Sciences at the University of Washington School of Medicine in Seattle.
Abstract:
This article discusses ethical responsibility and legal liability issues regarding use of IBM Watson™ for clinical decision making. In a case, a patient presents with symptoms of leukemia. Benefits and limitations of using Watson or other intelligent clinical decision-making tools are considered, along with precautions that should be taken before consulting artificially intelligent systems. Guidance for health care professionals and organizations using artificially intelligent tools to diagnose and to develop treatment recommendations are also offered.
Related Concept Videos
Groupthink
DNA as a Genetic Template
Group Polarization
Trait and State Self-Esteem
Confirmation Biases
Surveys


